Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Investing personality Jim Cramer recently called Recursion Pharmaceuticals a meme stock. The facts don't back up that position, though. Recursion may not be a meme stock, but that doesn't make it a ...

LAS VEGAS (AP) Tounde Yessoufou scored 18 points to lead short-handed Baylor Bears to a 91-81 victory over San Diego State Aztecs on Wednesday night in a Players Era tournament consolation game. All ...

Land is unique; there is no more of it being made. It’s for this reason families will hold tight to farms, ranches and coastal property for continued lifetime income, appreciation and, of course, ...

Capehart and Wehner on Trump’s reaction to the National Guard shooting Jonathan Capehart of MS NOW and Peter Wehner, a contributing writer at The Atlantic and a senior fellow at the Trinity Forum, ...